Terms: = Germ cell tumor AND JAK1, ENSG00000162434, P23458, JTK3, JAK1B, JAK1A, 3716
87 results:
1. Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma.
Song Q; Zhang X; Liu W; Wei H; Liang W; Zhou Y; Ding Y; Ji F; Ho-Kwan Cheung A; Wong N; Yu J
J Hepatol; 2023 Dec; 79(6):1352-1365. PubMed ID: 37459922
[TBL] [Abstract] [Full Text] [Related]
2. The Effect of 5-aza,2'-deoxyCytidine (5 AZA CdR or Decitabine) on Extrinsic, Intrinsic, and JAK/STAT Pathways in Neuroblastoma and Glioblastoma cells Lines.
Sanaei M; Kavoosi F
Asian Pac J Cancer Prev; 2023 Jun; 24(6):1841-1854. PubMed ID: 37378911
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and toxicity of anti-vascular endothelial growth receptor tyrosine kinase inhibitors in patients with neuroendocrine tumours - A systematic review and meta-analysis.
Das S; Phillips S; Lee CL; Agarwal R; Bergsland E; Strosberg J; Chan JA; LaFerriere H; Ramirez RA; Berlin J; Dasari A
Eur J Cancer; 2023 Mar; 182():43-52. PubMed ID: 36738541
[TBL] [Abstract] [Full Text] [Related]
4. Ruxolitinib enhances cytotoxic and apoptotic effects of temozolomide on glioblastoma cells by regulating WNT signaling pathway-related genes.
Goker Bagca B; Ozates NP; Biray Avci C
Med Oncol; 2022 Dec; 40(1):37. PubMed ID: 36460932
[TBL] [Abstract] [Full Text] [Related]
5. Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors.
Zhang F; Zhang Q; Zhu J; Yao B; Ma C; Qiao N; He S; Ye Z; Wang Y; Han R; Feng J; Wang Y; Qin Z; Ma Z; Li K; Zhang Y; Tian S; Chen Z; Tan S; Wu Y; Ran P; Wang Y; Ding C; Zhao Y
Cell Res; 2022 Dec; 32(12):1047-1067. PubMed ID: 36307579
[TBL] [Abstract] [Full Text] [Related]
6. Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling.
Shen H; Huang F; Zhang X; Ojo OA; Li Y; Trummell HQ; Anderson JC; Fiveash J; Bredel M; Yang ES; Willey CD; Chong Z; Bonner JA; Shi LZ
Nat Commun; 2022 Aug; 13(1):5013. PubMed ID: 36008408
[TBL] [Abstract] [Full Text] [Related]
7. Coexisting Alterations of MHC Class I Antigen Presentation and IFNγ Signaling Mediate Acquired Resistance of Melanoma to Post-PD-1 Immunotherapy.
Nielsen M; Presti M; Sztupinszki Z; Jensen AWP; Draghi A; Chamberlain CA; Schina A; Yde CW; Wojcik J; Szallasi Z; Crowther MD; Svane IM; Donia M
Cancer Immunol Res; 2022 Oct; 10(10):1254-1262. PubMed ID: 35969233
[TBL] [Abstract] [Full Text] [Related]
8. Cytoplasmic LMO2-LDB1 Complex Activates STAT3 Signaling through Interaction with gp130-JAK in Glioma Stem cells.
Park CG; Choi SH; Lee SY; Eun K; Park MG; Jang J; Jeong HJ; Kim SJ; Jeong S; Lee K; Kim H
Cells; 2022 Jun; 11(13):. PubMed ID: 35805116
[TBL] [Abstract] [Full Text] [Related]
9. Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma cells.
Margolis N; Moalem H; Meirson T; Galore-Haskel G; Markovits E; Baruch EN; Vizel B; Yeffet A; Kanterman-Rifman J; Debby A; Besser MJ; Schachter J; Markel G
Cancer Immunol Res; 2022 Sep; 10(9):1127-1140. PubMed ID: 35731225
[TBL] [Abstract] [Full Text] [Related]
10. Be Easy and Chill: Melanoma cells Tell Lymph Node Fibroblasts to Relax.
Lund AW
Cancer Res; 2022 May; 82(9):1692-1694. PubMed ID: 35502545
[TBL] [Abstract] [Full Text] [Related]
11. Secretion of IL1 by Dedifferentiated Melanoma cells Inhibits jak1-STAT3-Driven Actomyosin Contractility of Lymph Node Fibroblastic Reticular cells.
Rovera C; Berestjuk I; Lecacheur M; Tavernier C; Diazzi S; Pisano S; Irondelle M; Mallavialle A; Albrengues J; Gaggioli C; Girard CA; Passeron T; Deckert M; Tartare-Deckert S; Prod'homme V
Cancer Res; 2022 May; 82(9):1774-1788. PubMed ID: 35502542
[TBL] [Abstract] [Full Text] [Related]
12. CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours.
Larson RC; Kann MC; Bailey SR; Haradhvala NJ; Llopis PM; Bouffard AA; Scarfó I; Leick MB; Grauwet K; Berger TR; Stewart K; Anekal PV; Jan M; Joung J; Schmidts A; Ouspenskaia T; Law T; Regev A; Getz G; Maus MV
Nature; 2022 Apr; 604(7906):563-570. PubMed ID: 35418687
[TBL] [Abstract] [Full Text] [Related]
13. Effects of Vitexin, a Natural Flavonoid Glycoside, on the Proliferation, Invasion, and Apoptosis of Human U251 Glioblastoma cells.
Huang J; Zhou Y; Zhong X; Su F; Xu L
Oxid Med Cell Longev; 2022; 2022():3129155. PubMed ID: 35281458
[TBL] [Abstract] [Full Text] [Related]
14. Association of Tim-3/Gal-9 Axis with NLRC4 Inflammasome in Glioma Malignancy: Tim-3/Gal-9 Induce the NLRC4 Inflammasome.
Sim J; Park J; Kim S; Hwang S; Sung K; Lee JE; Yang S; Cho K; Lee S; Moon JS; Ahn J; Lim J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216164
[TBL] [Abstract] [Full Text] [Related]
15. Targeting the gp130/STAT3 Axis Attenuates tumor Microenvironment Mediated Chemoresistance in Group 3 Medulloblastoma cells.
Sreenivasan L; Li LV; Leclair P; Lim CJ
Cells; 2022 Jan; 11(3):. PubMed ID: 35159191
[TBL] [Abstract] [Full Text] [Related]
16. SOX10 Regulates Melanoma Immunogenicity through an IRF4-IRF1 Axis.
Yokoyama S; Takahashi A; Kikuchi R; Nishibu S; Lo JA; Hejna M; Moon WM; Kato S; Zhou Y; Hodi FS; Song JS; Sakurai H; Fisher DE; Hayakawa Y
Cancer Res; 2021 Dec; 81(24):6131-6141. PubMed ID: 34728538
[TBL] [Abstract] [Full Text] [Related]
17. Transcriptomic profiling in canines and humans reveals cancer specific gene modules and biological mechanisms common to both species.
Tawa GJ; Braisted J; Gerhold D; Grewal G; Mazcko C; Breen M; Sittampalam G; LeBlanc AK
PLoS Comput Biol; 2021 Sep; 17(9):e1009450. PubMed ID: 34570764
[TBL] [Abstract] [Full Text] [Related]
18. Immunostimulatory bacterial antigen-armed oncolytic measles virotherapy significantly increases the potency of anti-PD1 checkpoint therapy.
Panagioti E; Kurokawa C; Viker K; Ammayappan A; Anderson SK; Sotiriou S; Chatzopoulos K; Ayasoufi K; Johnson AJ; Iankov ID; Galanis E
J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34196308
[TBL] [Abstract] [Full Text] [Related]
19. USP22 deficiency in melanoma mediates resistance to T cells through IFNγ-jak1-STAT1 signal axis.
Li M; Xu Y; Liang J; Lin H; Qi X; Li F; Han P; Gao Y; Yang X
Mol Ther; 2021 Jun; 29(6):2108-2120. PubMed ID: 33601053
[TBL] [Abstract] [Full Text] [Related]
20. Mutations in the IFNγ-JAK-STAT Pathway Causing Resistance to Immune Checkpoint Inhibitors in Melanoma Increase Sensitivity to Oncolytic Virus Treatment.
Nguyen TT; Ramsay L; Ahanfeshar-Adams M; Lajoie M; Schadendorf D; Alain T; Watson IR
Clin Cancer Res; 2021 Jun; 27(12):3432-3442. PubMed ID: 33593882
[TBL] [Abstract] [Full Text] [Related]
[Next]
